These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22958539)

  • 41. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: further analysis of the data of the 2015-2016 Tanzania demographic and health survey and malaria indicator survey.
    Mushi V; Mbotwa CH; Zacharia A; Ambrose T; Moshi FV
    Malar J; 2021 Feb; 20(1):75. PubMed ID: 33549094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine (IPTp-SP) among postpartum women in Zomba District, Malawi: a cross-sectional study.
    Azizi SC; Chongwe G; Chipukuma H; Jacobs C; Zgambo J; Michelo C
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):108. PubMed ID: 29678150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malaria-related ideational factors and other correlates associated with intermittent preventive treatment among pregnant women in Madagascar.
    Awantang GN; Babalola SO; Koenker H; Fox KA; Toso M; Lewicky N
    Malar J; 2018 Apr; 17(1):176. PubMed ID: 29695231
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why are IPTp coverage targets so elusive in sub-Saharan Africa? A systematic review of health system barriers.
    Thiam S; Kimotho V; Gatonga P
    Malar J; 2013 Oct; 12():353. PubMed ID: 24090252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake challenges of intermittent preventive malaria therapy among pregnant women and their health care providers in the Upper West Region of Ghana: A mixed-methods study.
    Dun-Dery F; Meissner P; Beiersmann C; Kuunibe N; Winkler V; Albrecht J; Müller O
    Parasite Epidemiol Control; 2021 Nov; 15():e00222. PubMed ID: 34632123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community delivery of malaria intermittent preventive treatment in pregnancy: protocol of a quasi-experimental evaluation through multistage cluster sampling household surveys in four sub-Saharan African countries.
    Pons-Duran C; Llach M; Sanz S; Ramírez M; Méndez S; Roman E; Tholandi M; Pagnoni F; Menendez C; González R
    BMJ Open; 2021 Mar; 11(3):e044680. PubMed ID: 33766844
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of coverage of preventive treatment and insecticide-treated mosquito nets in pregnant women attending antenatal care services in 11 districts in Mozambique in 2011: the critical role of supply chain.
    Salomão C; Sacarlal J; Gudo ES
    Malar J; 2017 May; 16(1):223. PubMed ID: 28545540
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adherence to intermittent preventive treatment for malaria with sulphadoxine-pyrimethamine and outcome of pregnancy among parturients in South East Nigeria.
    Onyebuchi AK; Lawani LO; Iyoke CA; Onoh CR; Okeke NE
    Patient Prefer Adherence; 2014; 8():447-52. PubMed ID: 24741295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing adherence to the new intermittent preventive treatment of malaria in pregnancy policy in Keta District of the Volta region, Ghana.
    Vandy AO; Peprah NY; Jerela JY; Titiati P; Manu A; Akamah J; Maya ET; Torpey K
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):424. PubMed ID: 31747927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: an analysis of demographic and health survey 2015-2016.
    Azizi SC
    BMC Public Health; 2020 Mar; 20(1):335. PubMed ID: 32178658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlates of uptake of optimal doses of sulfadoxine-pyrimethamine for prevention of malaria during pregnancy in East-Central Uganda.
    Martin MK; Venantius KB; Patricia N; Bernard K; Keith B; Allen K; Godfrey A; Rogers T; Damazo KT; Dathan BM
    Malar J; 2020 Apr; 19(1):153. PubMed ID: 32295601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Community-based delivery of intermittent preventive treatment of malaria in pregnancy in Burkina Faso: a qualitative study.
    Burke D; Tiendrebeogo J; Emerson C; Youll S; Gutman J; Badolo O; Savadogo Y; Vibbert K; Wolf K; Brieger W
    Malar J; 2021 Jun; 20(1):277. PubMed ID: 34162384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso.
    Gutman JR; Stephens DK; Tiendrebeogo J; Badolo O; Dodo M; Burke D; Williamson J; Vibbert K; Youll SJ; Savadogo Y; Brieger WR
    Malar J; 2020 Aug; 19(1):282. PubMed ID: 32758233
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.
    Harrington WE; Mutabingwa TK; Kabyemela E; Fried M; Duffy PE
    Clin Infect Dis; 2011 Aug; 53(3):224-30. PubMed ID: 21765070
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The acceptability of intermittent screening and treatment versus intermittent preventive treatment during pregnancy: results from a qualitative study in Northern Ghana.
    Pell C; Meñaca A; Chatio S; Hodgson A; Tagbor H; Pool R
    Malar J; 2014 Nov; 13():432. PubMed ID: 25404126
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Underreporting and Missed Opportunities for Uptake of Intermittent Preventative Treatment of Malaria in Pregnancy (IPTp) in Mali.
    Hurley EA; Harvey SA; Rao N; Diarra NH; Klein MC; Diop SI; Doumbia SO
    PLoS One; 2016; 11(8):e0160008. PubMed ID: 27494250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.